The Durability of Anti-TNF Therapy for Crohn’s Disease Is Higher in Anti-TNF Naïve Patients and Increases With Proactive Therapeutic Drug Monitoring
Robert Gilmore(The University of Queensland), Emily K. Wright(Brigham and Women's Hospital), Aathavan Shanmuga Anandan(Mater Hospital), Jakob Begun(Translational Research Institute), Yoon‐Kyo An(Mater Hospital), George Tambakis(Royal Brisbane and Women's Hospital), Lyman Lin(St Vincent's Hospital Melbourne), Richard Fernandes(The University of Queensland), Tamar Schildkraut(St Vincent's Hospital Melbourne), Amirah Etchegaray(Mater Adult Hospital), Riddhi Joshi(St Vincent's Hospital Melbourne), Sara Vorgin(The University of Melbourne), Moshe Loebenstein(Monash Health)
Cited by 1
Related Papers
Deep Resequencing of GWAS Loci Identifies Rare Variants in CARD9, IL23R and RNF186 That Are Associated with Ulcerative Colitis
|PLoS Genetics|2013|217
Systematic Review and Meta-analysis: Optimal Salvage Therapy in Acute Severe Ulcerative Colitis
|Inflammatory Bowel Diseases|2019|94
Adhesion formation after previous caesarean section-a meta-analysis and systematic review
|BJOG An International Journal of Obstetrics & Gynaecology|2010|73
Gastrointestinal ultrasound in inflammatory bowel disease care: Patient perceptions and impact on disease‐related knowledge
|JGH Open|2019|62
Monitoring Inflammatory Bowel Disease in Pregnancy Using Gastrointestinal Ultrasonography
|Journal of Crohn s and Colitis|2020|62